Alanine scanning mutagenesis of SP70 epitope in characterizing species‑specific antibodies induced by enterovirus 71‑based antigens

Gao,Meng; Zhang,Feng; Zhu,Yun; Gao,Limei; Jiang,Yunshui; Luo,Yongneng; Zhuang,Fangchang; Mao,Zian; Mao,Jiangsen

doi:10.3892/mmr.2017.7992

Alanine scanning mutagenesis of SP70 epitope in characterizing species‑specific antibodies induced by enterovirus 71‑based antigens

Authors:
- Meng Gao
- Feng Zhang
- Yun Zhu
- Limei Gao
- Yunshui Jiang
- Yongneng Luo
- Fangchang Zhuang
- Zian Mao
- Jiangsen Mao
View Affiliations

Affiliations: Zhejiang Provincial Key Laboratory of Vaccine R&D, Institute of Virology, Zhejiang Academy of Medical Science, Hangzhou, Zhejiang 310053, P.R. China
Published online on: November 6, 2017 https://doi.org/10.3892/mmr.2017.7992
Pages: 1006-1014
Copyright: © Gao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The enterovirus 71 (EV71) SP70 epitope, derived from amino acids 208‑222 of VP1, is a neutralizing epitope. The present study aimed to assess the inter‑species differences of the antibodies induced by EV71‑based antigens in responses to SP70 mutant peptides. BALB/c mice and Lou/C rats were immunized with EV71 SP70. Monoclonal antibodies (Mabs) were produced by hybridoma clones. Serum polyclonal antibodies (Pabs) were produced from BALB/c mice and New Zealand white rabbits immunized with recombinant EV71 VP1 (rEV71‑VP1) protein or inactivated EV71. Micro‑neutralization and immunofluorescence assays were used to evaluate the capacity of the antibodies to bind to EV71. Reactivity of Mabs and Pabs to mutated SP70 were determined by alanine scanning mutagenesis. Furthermore, serums from EV71‑infected patients were collected to examine the affinity of SP70 antibody in the serum to mutated SP70, using competitive ELISA. The binding affinity of mouse Mabs to the SP70 epitope was increased by alanine substitution at sites of 210, 212, 213, 214, and 221. The binding affinity of rat Mabs to the SP70 epitope was increased by alanine substitution at sites 210, 217, 219, and 221. Mouse serum Pabs elicited by inactivated EV71 bound wild‑type SP70, but lost affinity for mutated peptides. Conversely, rabbit serum Pabs elicited by inactivated EV71 robustly recognized SP70 mutants. Mouse serum Pabs elicited by rEV71‑VP1 presented the same trend as mouse Mabs. Mutations at sites 214, 215, and 217 led to loss of recognition by rabbit Pabs elicited by rEV71‑VP1, while most mutations did not influence antibody binding. Compared with the wild‑type, mutations at the sites 209, 219 and 221 of SP70 lead to increased affinity with the serum antibodies produced by the EV71‑infected patients. Antibody responses triggered by inactivated EV71, rEV71‑VP1 and EV71 SP70 differed among species in neutralizing capacity and affinity for SP70 mutant peptides.

View Figures

View References

1	Sanders SA, Herrero LJ, McPhie K, Chow SS, Craig ME, Dwyer DE, Rawlinson W and McMinn PC: Molecular epidemiology of enterovirus 71 over two decades in an Australian urban community. Arch Virol. 151:1003–1013. 2006. View Article : Google Scholar : PubMed/NCBI
2	Sato C, Syoji M, Ueki Y, Sato Y, Okimura Y, Saito N, Kikuchi N, Yagi T and Numakura H: Isolation of enterovirus 71 from patients with hand, foot and mouth disease in a local epidemic on March 2006, in Miyagi prefecture, Japan. Jpn J Infect Dis. 59:3482006.PubMed/NCBI
3	Chang LY: Enterovirus 71 in Taiwan. Pediatr Neonatol. 49:103–112. 2008. View Article : Google Scholar : PubMed/NCBI
4	Tee KK, Takebe Y and Kamarulzaman A: Emerging and re-emerging viruses in Malaysia, 1997–2007. Int J Infect Dis. 13:307–318. 2009. View Article : Google Scholar : PubMed/NCBI
5	Lum LC, Wong KT, Lam SK, Chua KB and Goh AY: Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis. Lancet. 352:13911998. View Article : Google Scholar : PubMed/NCBI
6	Mao LX, Wu B, Bao WX, Han FA, Xu L, Ge QJ, Yang J, Yuan ZH, Miao CH, Huang XX, et al: Epidemiology of hand, foot, and mouth disease and genotype characterization of enterovirus 71 in Jiangsu, China. J Clin Virol. 49:100–104. 2010. View Article : Google Scholar : PubMed/NCBI
7	Zhang Y, Tan XJ, Wang HY, Yan DM, Zhu SL, Wang DY, Ji F, Wang XJ, Gao YJ, Chen L, et al: An outbreak of hand, foot and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol. 44:262–267. 2009. View Article : Google Scholar : PubMed/NCBI
8	Chan KP, Goh KT, Chong CY, Teo ES, Lau G and Ling AE: Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis. 9:78–85. 2003. View Article : Google Scholar : PubMed/NCBI
9	Chang LY, Lin TY, Huang YC, Tsao KC, Shih SR, Kuo ML, Ning HC, Chung PW and Kang CM: Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. Pediatr Infect Dis J. 18:1092–1096. 1999. View Article : Google Scholar : PubMed/NCBI
10	Wang SM, Liu CC, Tseng HW, Wang JR, Huang CC, Chen YJ, Yang YJ, Lin SJ and Yeh TF: Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis. 29:184–190. 1999. View Article : Google Scholar : PubMed/NCBI
11	Xu J, Qian Y, Wang S, Serrano JM, Li W, Huang Z and Lu S: EV71: An emerging infectious disease vaccine target in the Far East? Vaccine. 28:3516–3521. 2010. View Article : Google Scholar : PubMed/NCBI
12	Foo DG, Alonso S, Chow VT and Poh CL: Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide. Microbes Infect. 9:1299–1306. 2007. View Article : Google Scholar : PubMed/NCBI
13	Foo DG, Alonso S, Phoon MC, Ramachandran NP, Chow VT and Poh CL: Identification of neutralizing linear epitopes from the VP1 capsid protein of enterovirus 71 using synthetic peptides. Virus Res. 125:61–68. 2007. View Article : Google Scholar : PubMed/NCBI
14	Lee MS and Chang LY: Development of enterovirus 71 vaccines. Expert Rev Vaccines. 9:149–156. 2010. View Article : Google Scholar : PubMed/NCBI
15	Brown BA and Pallansch MA: Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res. 39:195–205. 1995. View Article : Google Scholar : PubMed/NCBI
16	Lim XF, Jia Q, Chow VT and Kwang J: Characterization of a novel monoclonal antibody reactive against the N-terminal region of enterovirus 71 VP1 capsid protein. J Virol Methods. 188:76–82. 2013. View Article : Google Scholar : PubMed/NCBI
17	Yokoyama WM: Production of monoclonal antibodies. Curr Protoc Cell Biol Chapter. 16:Unit 16 1. 2001. View Article : Google Scholar
18	Yokoyama WM, Christensen M, Dos Santos G, Miller D, Ho J, Wu T, Dziegelewski M and Neethling FA: Production of monoclonal antibodies. Curr Protoc Immunol. 102:Unit 2.5. 2013. View Article : Google Scholar : PubMed/NCBI
19	Wunderlich K, Juozapaitis M, Ranadheera C, Kessler U, Martin A, Eisel J, Beutling U, Frank R and Schwemmle M: Identification of high-affinity PB1-derived peptides with enhanced affinity to the PA protein of influenza A virus polymerase. Antimicrob Agents Chemother. 55:696–702. 2011. View Article : Google Scholar : PubMed/NCBI
20	Ping J, Li C, Deng G, Jiang Y, Tian G, Zhang S, Bu Z and Chen H: Single-amino-acid mutation in the HA alters the recognition of H9N2 influenza virus by a monoclonal antibody. Biochem Biophys Res Commun. 371:168–171. 2008. View Article : Google Scholar : PubMed/NCBI
21	Saha D, Lefebvre DJ, Ooms K, Huang L, Delputte PL, Van Doorsselaere J and Nauwynck HJ: Single amino acid mutations in the capsid switch the neutralization phenotype of porcine circovirus 2. J Gen Virol. 93:1548–1555. 2012. View Article : Google Scholar : PubMed/NCBI
22	Liu CC, Chou AH, Lien SP, Lin HY, Liu SJ, Chang JY, Guo MS, Chow YH, Yang WS, Chang KH, et al: Identification and characterization of a cross-neutralization epitope of enterovirus 71. Vaccine. 29:4362–4372. 2011. View Article : Google Scholar : PubMed/NCBI
23	Plevka P, Perera R, Cardosa J, Kuhn RJ and Rossmann MG: Crystal structure of human enterovirus 71. Science. 336:12742012. View Article : Google Scholar : PubMed/NCBI